NCT02276612 Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents Status COMPLETED Phase PHASE2/PHASE3
NCT02272946 Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Status COMPLETED Phase PHASE2
NCT02272829 Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain Status COMPLETED Phase NA
NCT02269462 A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation Status COMPLETED Phase N/A
NCT02258685 Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients. Status COMPLETED Phase N/A
NCT02252471 Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females Status COMPLETED Phase NA
NCT02251236 Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals Status COMPLETED Phase NA
NCT02249962 Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART Status COMPLETED Phase N/A
NCT02248558 Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing Status COMPLETED Phase NA
NCT02245022 Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study Status COMPLETED Phase PHASE2/PHASE3
NCT02242799 Dolutegravir Interactions With Artemisinin-based Combination Therapies Status COMPLETED Phase PHASE1
NCT02238327 Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Status COMPLETED Phase N/A